High-level production of N-terminal pro-brain natriuretic peptide, as a calibrant of heart failure diagnosis, in Escherichia coli

2019 ◽  
Vol 103 (12) ◽  
pp. 4779-4788 ◽  
Author(s):  
Young Su Kim ◽  
Nadia Karisa ◽  
Woo Young Jeon ◽  
Hongweon Lee ◽  
Yeu-chun Kim ◽  
...  
Keyword(s):  
Heart Failure ◽  
Escherichia Coli ◽  
Brain Natriuretic Peptide ◽  
Natriuretic Peptide ◽  
Failure Diagnosis ◽  
High Level ◽  
Heart Failure Diagnosis ◽  
Level Production

scholarly journals Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care

2003 ◽  
Vol 42 (10) ◽  
pp. 1793-1800 ◽  
Author(s):  
Susan P. Wright ◽  
Robert N. Doughty ◽  
Ann Pearl ◽  
Greg D. Gamble ◽  
Gillian A. Whalley ◽  
...  
Keyword(s):  
Heart Failure ◽  
Primary Care ◽  
Brain Natriuretic Peptide ◽  
Natriuretic Peptide ◽  
Failure Diagnosis ◽  
Amino Terminal ◽  
Heart Failure Diagnosis

Towards label-free, wash-free and quantitative B-type natriuretic peptide detection for heart failure diagnosis

Nanoscale ◽  
2019 ◽  
Vol 11 (39) ◽  
pp. 18347-18357 ◽  
Author(s):  
Zhi Li ◽  
Irfani R. Ausri ◽  
Yael Zilberman ◽  
Xiaowu (Shirley) Tang
Keyword(s):  
Heart Failure ◽  
Natriuretic Peptide ◽  
High Sensitivity ◽  
Integrated System ◽  
Failure Diagnosis ◽  
Proof Of Concept ◽  
Label Free ◽  
Peptide Detection ◽  
Significant Step ◽  
Heart Failure Diagnosis

A unique integrated system demonstrating a significant step beyond proof-of-concept high sensitivity carbon nanotube based sensors for quantitative reading of B-type natriuretic peptide (BNP) in outpatient blood is presented.

scholarly journals B-Type Natriuretic Peptide Testing and the Accuracy of Heart Failure Diagnosis in the Emergency Department

2010 ◽  
Vol 3 (1) ◽  
pp. 104-110 ◽  
Author(s):  
Amaali Lokuge ◽  
Louisa Lam ◽  
Peter Cameron ◽  
Henry Krum ◽  
de Villiers Smit ◽  
...  
Keyword(s):  
Heart Failure ◽  
Emergency Department ◽  
Natriuretic Peptide ◽  
Failure Diagnosis ◽  
Heart Failure Diagnosis

Chronic heart failure diagnosis: biomarkers

ESC CardioMed ◽  
2018 ◽  
pp. 1778-1781
Author(s):  
Christian Mueller
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Natriuretic Peptide ◽  
Natriuretic Peptides ◽  
Point Of Care ◽  
Failure Diagnosis ◽  
Central Laboratory ◽  
Important Advance ◽  
Cardiac Stress ◽  
Heart Failure Diagnosis

Natriuretic peptides including B-type natriuretic peptide (BNP), N-terminal (NT)-proBNP, and midregional pro-atrial natriuretic peptide (MR-proANP) are the biomarkers of choice in the diagnosis of heart failure. Assays measuring either BNP, NT-proBNP, or MR-proANP are widely available and run on large analysers operating in the central laboratory or as point-of-care options. Natriuretic peptides are considered quantitative markers of haemodynamic cardiac stress and therefore quantitative markers of heart failure itself. The clinical introduction of natriuretic peptides constitutes the most important advance in the diagnosis of heart failure in the last decade.

Chronic heart failure diagnosis: biomarkers

ESC CardioMed ◽  
2018 ◽  
pp. 1778-1781
Author(s):  
Christian Mueller
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Natriuretic Peptide ◽  
Natriuretic Peptides ◽  
Point Of Care ◽  
Failure Diagnosis ◽  
Central Laboratory ◽  
Important Advance ◽  
Cardiac Stress ◽  
Heart Failure Diagnosis

Natriuretic peptides including B-type natriuretic peptide (BNP), N-terminal (NT)-proBNP, and midregional pro-atrial natriuretic peptide (MR-proANP) are the biomarkers of choice in the diagnosis of heart failure. Assays measuring either BNP, NT-proBNP, or MR-proANP are widely available and run on large analysers operating in the central laboratory or as point-of-care options. Natriuretic peptides are considered quantitative markers of haemodynamic cardiac stress and therefore quantitative markers of heart failure itself. The clinical introduction of natriuretic peptides constitutes the most important advance in the diagnosis of heart failure in the last decade.

Chronic heart failure diagnosis: biomarkers

ESC CardioMed ◽  
2018 ◽  
pp. 1778-1781
Author(s):  
Christian Mueller
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Natriuretic Peptide ◽  
Natriuretic Peptides ◽  
Point Of Care ◽  
Failure Diagnosis ◽  
Central Laboratory ◽  
Important Advance ◽  
Cardiac Stress ◽  
Heart Failure Diagnosis

Natriuretic peptides including B-type natriuretic peptide (BNP), N-terminal (NT)-proBNP, and midregional pro-atrial natriuretic peptide (MR-proANP) are the biomarkers of choice in the diagnosis of heart failure. Assays measuring either BNP, NT-proBNP, or MR-proANP are widely available and run on large analysers operating in the central laboratory or as point-of-care options. Natriuretic peptides are considered quantitative markers of haemodynamic cardiac stress and therefore quantitative markers of heart failure itself. The clinical introduction of natriuretic peptides constitutes the most important advance in the diagnosis of heart failure in the last decade.

Sign in / Sign up

Export Citation Format

Share Document